Loading...
Please wait, while we are loading the content...
Fp Receptor Antagonsts or Pgf2 Alpha Antagonsts for Treating Pathological Conditions of the Uterus
| Content Provider | Semantic Scholar |
|---|---|
| Author | Merkel, Edwin V. |
| Copyright Year | 2017 |
| Abstract | A method of treating or preventing a pathological condition of the uterus in an female individual, the method comprising administering to the individual at least one agent that prevents PGF2 having its effect on the FP receptor. Typi cally, the pathological condition is uterine cancer, fibroids or endometriosis. Patent Application Publication Jan. 4, 2007 Sheet 1 of 5 US 2007/0004620 A1 Figure 1: FP in-situ nybridisation in human endometrium and adenocarcinoma |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://patentimages.storage.googleapis.com/c9/fb/50/19b0dc87c89ba3/US20070004620A1.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |